It was reported that during use of the device for a cardiopulmonary bypass (cpb) procedure, the venous oxygen saturation (svo2) displayed a higher than expected pre-in-vivo.As a mitigation an in-vivo calibration was performed.The surgical procedure was completed successfully.There was no delay, no blood loss, nor adverse consequences to the patient.Per clinical review: the manufacturer's clinical specialist spoke with the perfusionist about the concern he had with the blood parameter monitor (bpm) svo2 readings on the new bpm versus what he was used to seeing on the old bpm svo2 pre-in-vivo.During three previous procedures before the informed date of february 3, 2020, the team stated that the svo2 values were reading different compared to the old bpm and were on the higher side.The clinical specialist conferred with the software team of the difference in expected pre-in-vivo values from the two devices and discussed this with the perfusionist.The perfusionist was informed that the expected/listed accuracy values are post the first in-vivo and all decisions should be made with confirmation from a blood gas analyzer.He stated post in-vivo the values followed as expected.There was no blood loss on these procedures.There was no harm or delay in the continuation of the surgical procedures.The question from the user was a usability/clinical question that was appropriately answered.
|
The reported complaint was confirmed.The issue was observed prior to an in-vivo calibration.After the user calibrated, post in-vivo, the values were accurate and the unit operated as intended.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
|